Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2706
Title: Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study
Authors: Aronica, E.
Hulshof, H.
Samueli, S.
Benova, B.
Kwiatkowski, D. J.
Curatolo, P.
Jozwiak, S.
Lagae, L.
Moavero, R.
Benvenuto, A.
Emberti Gialloreti, L.
Siracusano, M.
Kotulska, K.
Weschke, B.
Riney, K.
Jansen, F. E.
Feucht, M.
Krsek, P.
Nabbout, R.
Jansen, A. C.
Wojdan, K.
Borkowska, J.
Sadowski, K.
Hertzberg, C.
Issue Date: 2019
Source: Jun 3 8, (6), 2019
Journal: J Clin Med
Abstract: Autism spectrum disorder (ASD) is highly prevalent in subjects with Tuberous Sclerosis Complex (TSC), but we are not still able to reliably predict which infants will develop ASD. This study aimed to identify the early clinical markers of ASD and/or developmental delay (DD) in infants with an early diagnosis of TSC. We prospectively evaluated 82 infants with TSC (6-24 months of age), using a detailed neuropsychological assessment (Bayley Scales of Infant Development-BSID, and Autism Diagnostic Observation Schedule-ADOS), in the context of the EPISTOP (Long-term, prospective study evaluating clinical and molecular biomarkers of EPIleptogenesiS in a genetic model of epilepsy-Tuberous SclerOsis ComPlex) project (NCT02098759). Normal cognitive developmental quotient at 12 months excluded subsequent ASD (negative predictive value 100%). The total score of ADOS at 12 months clearly differentiated children with a future diagnosis of ASD from children without (p = 0.012). Atypical socio-communication behaviors (p < 0.001) were more frequently observed than stereotyped/repetitive behaviors in children with ASD at 24 months. The combined use of BSID and ADOS can reliably identify infants with TSC with a higher risk for ASD at age 6-12 months, allowing for clinicians to target the earliest symptoms of abnormal neurodevelopment with tailored intervention strategies.2077-0383Moavero, Romina
Orcid: 0000-0002-6200-060x
Benvenuto, Arianna
Emberti Gialloreti, Leonardo
Siracusano, Martina
Kotulska, Katarzyna
Weschke, Bernhard
Riney, Kate
Jansen, Floor E
Feucht, Martha
Krsek, Pavel
Nabbout, Rima
Jansen, Anna C
Orcid: 0000-0002-3835-2824
Wojdan, Konrad
Borkowska, Julita
Sadowski, Krzystof
Hertzberg, Christoph
Hulshof, Hanna
Samueli, Sharon
Benova, Barbora
Aronica, Eleonora
Kwiatkowski, David J
Lagae, Lieven
Jozwiak, Sergiusz
Orcid: 0000-0003-3350-6326
Curatolo, Paolo
602391/European Community's Seventh Framework Programme/
Journal Article
J Clin Med. 2019 Jun 3;8(6):788. doi: 10.3390/jcm8060788.
DOI: 10.3390/jcm8060788
Keywords: *markers;*risk factors;*treatment;*tuberous sclerosis complex;*epilepsy;*diagnosis;*developmental delay;*epistop*autism;*intellectual disability
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

52
checked on Mar 25, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.